Diagnosis and clinical evaluation of nasopharyngeal carcinoma

Advances in Experimental Medicine and Biology

Volumn 778, Issue , 2013, Pages 1-9

  Khoo, Alan Soo Beng ^a   Pua, Kin Choo ^b  

^a INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

^b HOSPITAL PULAU PINANG   (Malaysia)

Author keywords

Cervical lymph node; Nasopharyngeal carcinoma; National comprehensive cancer network; Tumor node metastasis

Indexed keywords

ASYMPTOMATIC DISEASE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SCREENING; CANCER STAGING; CLINICAL EVALUATION; DELAYED DIAGNOSIS; EARLY DIAGNOSIS; ENDOSCOPY; HISTOPATHOLOGY; HUMAN; NASOPHARYNX; NASOPHARYNX CARCINOMA; NECK TUMOR; PRIORITY JOURNAL; RECURRENCE RISK; SCORING SYSTEM; TUMOR BIOPSY;

EID: 84908114348     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-1-4614-5947-7_1     Document Type: Chapter

References (36)

1. Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2006; 15(10):1765-1777.
2. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 International Agency for Research on Cancer, Lyon, France; 2010. http://globocan.iarc.fr.
3. Pathmanathan R, Prasad U, Chandrika G et al. Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia. Am J Pathol 1995; 146(6):1355-1367.
4. Prasad U. Cancer of the nasopharynx. A clinical analysis with anatomicopathological orientation. J R Coll Surg Edinb 1972; 17(2):108-117.
5. Prasad U. Fossa of Rosenmuller and nasopharyngeal carcinoma. Med J Malaysia 1979; 33(3):222-225.
6. Prasad U. Nasopharyngeal carcinoma in man. In: Reznik G, Stinson SF, eds. Nasal Tumors in Animals and Man. Boca Raton: CRC Press, 1983:151-185.
7. Prasad U, Pua KC. Nasopharyngeal carcinoma: a delay in diagnosis. Med J Malaysia 2000; 55(2):230-235.
8. Skinner DW, Van Hasselt CA, Tsao SY. Nasopharyngeal carcinoma: modes of presentation. Ann Otol Rhinol Laryngol 1991; 100(7):544-551.
9. Pua KC, Khoo AS, Yap YY et al. Nasopharyngeal Carcinoma Database. Med J Malaysia 2008; 63 Suppl C: 59-62.
10. Chan JKC, Bray F, McCarron P et al. Nasopharyngeal carcinoma. In: Barnes L, Eveson JW, Reichart P, Sidransky D, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours Vol 9. Lyon: IARC Press, 2005:85-97.
11. Prasad U. Cells of origin of nasopharyngeal carcinoma: an electron microscopic study. J Laryngol Otol 1974; 88(11):1087-1094.
12. Nicholls J, Niedobitek G. Histopathological diagnosis of nasopharyngeal carcinoma—Looking beyond the blue book. In: Busson P, ed. Nasopharyngeal Carcinoma: Keys for Translational Medicine and Biology. Austin/New York: Landes Bioscience/Springer Science+Business Media, 2012:10-22.
13. Taxy JB, Hidvegi DF, Battifora H. Nasopharyngeal carcinoma: antikeratin immunohistochemistry and electron microscopy. Am J Clin Pathol 1985; 83(3):320-325.
14. Purposes and Principles of Cancer Staging. In: Edge S, Byrd D, Compton C, eds. AJCC Cancer Staging Manual. 7th ed. New York: Springer, 2010:3-14.
15. NCCN. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Head and Neck Cancers. 2011. www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf.
16. Pharynx. In: Edge S, Byrd D, Compton C, eds. AJCC Cancer Staging Manual. 7th ed. New York: Springer, 2010:41-56.
17. Pathmanathan R, Prasad U, Sadler R et al. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 1995; 333(11):693-698.
18. Pak MW, To KF, Lo YM et al. Nasopharyngeal carcinoma in situ (NPCIS)—pathologic and clinical perspectives. Head Neck 2002; 24(11):989-995.
19. King AD, Vlantis AC, Tsang RK et al. Magnetic resonance imaging for the detection of nasopharyngeal carcinoma. AJNR Am J Neuroradiol 2006; 27(6):1288-1291.
20. Liao XB, Mao YP, Liu LZ et al. How does magnetic resonance imaging influence staging according to AJCC staging system for nasopharyngeal carcinoma compared with computed tomography? Int J Radiat Oncol Biol Phys 2008; 72(5):1368-1377.
21. Ma J, Liu L, Tang L et al. Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma: prognostic value and staging categories. Clin Cancer Res 2007; 13(5):1445-1452.
22. Tang L, Li L, Mao Y et al. Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma detected by magnetic resonance imaging: prognostic value and staging categories. Cancer 2008; 113(2):347-354.
23. Tham IW, Hee SW, Yap SP et al. Retropharyngeal nodal metastasis related to higher rate of distant metastasis in patients with N0 and N1 nasopharyngeal cancer. Head Neck 2009; 31(4):468-474.
24. Lin XP, Zhao C, Chen MY et al. Role of 18F-FDG PET/CT in diagnosis and staging of nasopharyngeal carcinoma. Ai Zheng 2008; 27(9):974-978.
25. Ng SH, Chan SC, Yen TC et al. Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up. Eur J Nucl Med Mol Imaging 2009; 36(1):12-22.
26. Chua ML, Ong SC, Wee JT et al. Comparison of 4 modalities for distant metastasis staging in endemic nasopharyngeal carcinoma. Head Neck 2009; 31(3):346-354.
27. Liu FY, Lin CY, Chang JT et al. 18F-FDG PET can replace conventional work-up in primary M staging of nonkeratinizing nasopharyngeal carcinoma. J Nuclear Med 2007; 48(10):1614-1619.
28. Comoretto M, Balestreri L, Borsatti E et al. Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT. Radiology 2008; 249(1):203-211.
29. Mao YP, Liang SB, Liu LZ et al. The N staging system in nasopharyngeal carcinoma with radiation therapy oncology group guidelines for lymph node levels based on magnetic resonance imaging. Clin Cancer Res 2008; 14(22):7497-7503.
30. Chen L, Mao YP, Xie FY et al. The seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in China. Radiother Oncol 2011.
31. Prasad U. Problems in the early diagnosis of nasopharyngeal carcinoma: A review of 40 cases. In: Prasad U, ed. Nasopharyngeal Carcinoma. Kuala Lumpur: University of Malaya Press, 2000:233-239.
32. Prasad UAD, Prathap K et al. Problem of occult primary in nasopharyngeal carcinoma. In: Prasad U, ed. Nasopharyngeal Carcinoma: Current Concepts. Kuala Lumpur: University of Malaya Press, 1983:11-15.
33. Kaur A, Chew CT, Lim-Tan SK. Fine needle aspiration of 123 head and neck masses—an initial experience. Ann Acad Med Singapore 1993; 22(3):303-306.
34. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, ed. Evaluation of Chemotherapeutic Agents: Columbia Univ Press, 1949:196.
35. Oken MM, Creech RH, Tormey DC et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5(6):649-655.
36. Lee AW, Foo W, Law SC et al. Recurrent nasopharyngeal carcinoma: the puzzles of long latency. Int J Radiat Oncol Biol Phys 1999; 44(1):149-156.